This 20-part series is designed to provide a comprehensive understanding of the microbiome, gut health, the gut-skin axis, and how the microbiome connects with the rest of the body in health and disease.
This activity has been designed to meet the educational needs of clinicians and non-clinicians involved in the care of patients with psoriasis.
- Review the concepts behind "Leaky Gut"
- Discuss the mechanisms and implications
- Evaluate its connection to skin disorders
- Review prognostic and therapeutic ramifications for clinicians
Disclosure of Conflicts of Interest
SynAptiv ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, SynAptiv identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by SynAptiv to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SynAptiv is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
|Name of Faculty||Reported Financial Relationship|
No financial relationships to disclose
|Peter Lio, MD||
Consulting Fees/Advisory Board. Grants/Research Support. Speakers Bureau. National Eczema Association, Modernizing Medicine, Johnson & Johnson Consumer Products, DermTap, Inc., Pierre Fabre Dermatologie, La Fondation pour la Dermatite Atopique (Foundation for Atopic Dermatitis), Valeant Pharmaceuticals International, IntraDerm Pharmaceuticals, Valeant Pharmaceuticals North America LLC, Regeneron, Sanofi US Services, Exeltis, AOBiome LLC, Theraplex, Odeza LLC, Realm Therapeutics, Pfizer Inc., La Roche-Posay Laboratorie Pharmaceutique, L’Oreal USA Inc., Menlo Therapeutics, Franklin BioScience, AbbVie, Syncere Skin Systems, Kiniksa Pharmaceuticals Ltd., Eli Lilly and Company, Unilever, gpower, inc., UCB, Altus Labs, Dermavant Sciences, Micreos Human Health B.V.-, Dermira, LearnHealth/LearnSkin, AbbVie, Medable, Verrica Pharmaceuticals Inc, TopMD, Amyris, Inc., LEO Laboratories Ltd (LEO Pharma)
|Name of Editor / Scientific Reviewer||Reported Financial Relationship|
|Raja Sivamani, MD MS AP||
Grants/Research Support: Regeneron Pharmaceuticals, Abbvie, Physicians Exclusive, Sytheon, Type A Deodorant
Ownership Interest/Stock Holder: LearnHealth – Spouse
Consultant: Regeneron Pharmaceuticals, Burt's Bees, Arbonne, Abbvie
The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
|Name of Content Manager||Reported Financial Relationship|
|Venita Sivamani, Planner||LearnHealth founder and shareholder|
|Planners at SynAptiv||No financial relationships to disclose|
All other faculty, planner and/or content managers have nothing to disclose nor do they have any vested interests or affiliations. All conflicts of interest have been resolved.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and LearnHealth. SynAptiv is accredited by the ACCME to provide continuing medical education for physicians.
SynAptiv designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
SynAptiv is accredited as a provider of continuing nursing education by the California Board of Registered Nursing. This CE activity provides 1.0 contact hour of continuing nursing education. SynAptiv is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 16031.
Method of Participation
Participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each quiz question, and 4) complete the evaluation form.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better. Statements of credit will be available once the evaluation form is completed.
The content, views, and opinions presented in this educational activity are those of the faculty/authors and do not necessarily reflect those of SynAptiv and/or LearnHealth. The faculty/authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Learners are required to adhere to the privacy and confidentiality policy as it relates to the CE activities provided on the Internet. Please see the policy at yourcesource.com/privacy.htm.